,
Ono, Fumiko
Akiyama, Sayako
Suzuki, Akifumi
Ikeda, Yoshinobu
Takahashi, Akira
Matsuoka, Hitoshi
Sasaki, Masahiro
Okamura, Tomonori
Yoshihara, Nariaki http://orcid.org/0000-0002-7317-9027
Funding for this research was provided by:
Bayer Yakuhin, Ltd (N/A)
Article History
Received: 25 December 2018
Accepted: 9 October 2019
First Online: 24 October 2019
Ethics approval and consent to participate
: This study followed the Ethical Guidelines for Human Clinical Research issued by the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labour and Welfare. Documented approval by the Institutional Ethics Committee/Institutional Review Board at the Research Institute for Brain and Blood Vessels-Akita on behalf of all participating clinics was received prior to the start of the study on October 5, 2015 (Approval number:15–10). This study was approved by the clinical research promotion network, Osaka Japan on August 27, 2015.Patients were required to provide written, informed consent to take part in the surveys if they chose to do so. In terms of data from medical chart review, they were secondary data collected in routine medical practice, and chart review was conducted anonymously; therefore, individual informed consent for data use was not required.
: Not Applicable.
: A Suzuki has received a consultation fee from Bayer Yakuhin, Ltd. and an honorarium for a scientific meeting from Pfizer Japan Inc. Y Ikeda has received a consultation fee from Bayer Yakuhin, Ltd. and an honorarium for a scientific lecture from Daiichi Sankyo Co., Ltd. M Sasaki has received a consultation fee from Bayer Yakuhin, Ltd. H Matsuoka has received a consultation fee and a technical guidance fee from Bayer Yakuhin, Ltd., an honorarium for a scientific lecture from Bristol-Myers Squibb K.K., and an honorarium for a manuscript and a scientific lecture from Daiichi Sankyo Co., Ltd. A Takahashi has received a consultation fee and an honorarium for his participation as a general practitioner in this study from Bayer Yakuhin, Ltd. T Okamura has received a consultation fee and honoraria for scientific lectures from Bayer Yakuhin, Ltd., an honorarium for an annual scientific meeting from Daiichi Sankyo Co., Ltd., and a grant from the Japan Agency for Medical Research and Development. S Akiyama, F Ono and N Yoshihara are employees of Bayer Yakuhin, Ltd.